Citigroup Maintains Neutral on Boston Scientific, Lowers Price Target to $44
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice TargetHot
Citigroup analyst Joanne Wuensch maintains Boston Scientific (NYSE:BSX) with a Neutral and lowers the price target from $48 to $44.
Citigroup analyst Joanne Wuensch maintains Boston Scientific (NYSE:BSX) with a Neutral and lowers the price target from $48 to $44.